Since much remains to be discovered in terms of etiology and pathophysiology, currently there is no “cure” for this condition.
However, there is a wide array of pharmacological options for managing the disease. Lithium has been traditionally the most widely prescribed mood stabilizer, but in the last 15 years new options have become available.
Typical antipsychotics have been successfully used for manic episodes, but some of the biggest therapeutic challenges are the treatment of bipolar depression and the prevention of new episodes.
The Psychopharmacology Institute has recently published a video lecture in which Dr. Flavio Guzmán summarizes the recent literature on FDA approved antipsychotics for the management of the different phases of bipolar disorder.
Click the link to watch the three-part video lecture:
– Mania and mixed states
– Bipolar depression
– Maintenance treatment